Literature DB >> 17949292

Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women.

Aspasia Tsezou1, Maria Tzetis, Eirini Giannatou, Constantinos Gennatas, Andreas Pampanos, Emmanuel Kanavakis, Sofia Kitsiou-Tzeli.   

Abstract

Uridine diphospho-glucuronosyltransferase 1 (UGT1A1) is involved in estradiol glucuronidation, which may play a central role in the etiology of breast cancer. A common insertion/deletion polymorphism in the TATAA-box of the promoter region of UGT1A1 results in decreased initiation of transcription, and has been associated with breast cancer risk in different ethnic groups. In the present study, the role of the above genetic variation at the UGT1A1 locus in breast cancer susceptibility was investigated in a homogeneous population. Our case-control study included 136 women with breast cancer and 186 healthy female controls of Greek origin. The polymorphism A(TA)nTAA in the promoter region of UGT1A1 gene was studied using the Fragment Analysis Software of an automated DNA sequencer and three genotypes (homozygous 7/7, heterozygous 6/7, and normal homozygous 6/6) were identified. No significant associations were observed between the 7/7 genotype and breast cancer risk, indicating that further studies in Caucasian women are needed to elucidate the role of UGT1A1 polymorphism in breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949292     DOI: 10.1089/gte.2007.0020

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  4 in total

1.  Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms.

Authors:  Christina M Street; Zhaohui Zhu; Moshe Finel; Michael H Court
Journal:  Xenobiotica       Date:  2016-03-21       Impact factor: 1.908

Review 2.  PharmGKB summary: very important pharmacogene information for UGT1A1.

Authors:  Julia M Barbarino; Cyrine E Haidar; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2014-03       Impact factor: 2.089

3.  Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study.

Authors:  Nazlisadat Seyed Khoei; Robert Carreras-Torres; Neil Murphy; Marc J Gunter; Paul Brennan; Karl Smith-Byrne; Daniela Mariosa; James Mckay; Tracy A O'Mara; Ruth Jarrett; Henrik Hjalgrim; Karin E Smedby; Wendy Cozen; Kenan Onel; Arjan Diepstra; Karl-Heinz Wagner; Heinz Freisling
Journal:  Cells       Date:  2021-02-15       Impact factor: 6.600

4.  Genetic variants in hormone-related genes and risk of breast cancer.

Authors:  Tess Clendenen; Anne Zeleniuch-Jacquotte; Isaac Wirgin; Karen L Koenig; Yelena Afanasyeva; Eva Lundin; Alan A Arslan; Tomas Axelsson; Asta Försti; Göran Hallmans; Kari Hemminki; Per Lenner; Nirmal Roy; Roy E Shore; Yu Chen
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.